Economic cost of dengue in Puerto Rico

American Journal of Tropical Medicine and Hygiene

Volumn 86, Issue 5, 2012, Pages 745-752

  Halasa, Yara A ^a   Shepard, Donald S ^a   Zeng, Wu ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ACUTE OTITIS MEDIA; ARTICLE; COST OF ILLNESS; DENGUE; ECONOMIC ASPECT; FUNDING; HOSPITAL PATIENT; HOSPITALIZATION COST; HUMAN; INFLUENZA; INSURANCE; MAJOR CLINICAL STUDY; PUERTO RICO;

ADULT; AMBULATORY CARE FACILITIES; CHILD; COST OF ILLNESS; COSTS AND COST ANALYSIS; DENGUE; HOSPITALIZATION; HUMANS; PUERTO RICO;

EID: 84861804759     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.11-0784     Document Type: Article

References (67)

1. Centers for Disease Control and Prevention, Division of Vector Borne Diseases, 2011. Dengue: Entomology and Ecology. Available at: http://www.cdc.gov/dengue/entomologyEcology/index.html. Accessed September 7, 2011.
2. Farrar J, Focks D, Gubler D, Barrera R, Guzman MG, Simmons C, Kalayanarooj S, Lum L, McCall PJ, Lloyd L, Horstick O, Dayal-Drager R, Nathan MB, Kroeger A, 2007. Towards a global dengue research agenda. Trop Med Int Health 12: 695-699.
3. Guzman A, Isturiz RE, 2010. Update on the global spread of dengue. Int J Antimicrob 36S: S40-S42.
4. Guha-Sapir D, Schimmer B, 2005. Dengue fever: new paradigm for changing epidemiology. Emerg Themes Epidemiol 2: 1-10.
5. Whitehorn J, Farrar J, 2010. Dengue. Br Med Bull 95: 161-173.
6. World Health Organization (WHO), 2009. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control - New Edition. Geneva, Switzerland: UNICEF, UNDP, World Bank, WHO.
7. Singhasivanon P, Jacobson J, 2009. Dengue is a major global health problem. Foreword. J Clin Virol 46: S1-S2.
8. Gubler DJ, 2011. Emerging vector-borne flavivirus diseases: are vaccines the solution? Vaccine 10: 563-565.
9. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martínez E, Nathan MB, Pelegrino JL, Simmons C, Yoksan S, Peeling RW, 2010. Dengue: a continuing global threat. Nat Rev Microbiol 8: S7-S16.
10. Beatty M, Beutels P, Meltzer MI, Shepard DS, Hombach J, Hutubessy R, Dessis D, Coudeville L, Dervaux B, Wichmann O, Margolis HS, Kuritsky JN, 2011. Health economics of dengue a systematic literature review and expert panel's assessment. Am J Trop Med Hyg 84: 473-488.
11. Kyle JL, Harris E, 2008. Global spread and persistence of dengue. Annu Rev Microbiol 62: 71-92.
12. Suaya JA, Shepard DS, Siqueira JB, Martelli CT, Lum LCS, Tan LH, Kongsin S, Jiamton S, Garrido F, Montaya R, Armien B, Huy R, Castillo L, Sah BK, Sughayyar R, Tyo KR, Halsted SB, 2009. Cost of dengue cases in eight countries in Americas and Asia, a prospective study. Am J Trop Med Hyg 80: 845-855.
13. World Health Organization Media Center, 2009. Dengue and Dengue Haemorrhagic Fever, Fact Sheet No. 117. Available at: http://www.who.int/ mediacentre/factsheets/fs117/en/index.html. Accessed December 10, 2009.
14. World Health Organization (WHO), 2006. Report of the Scientific Working Group on Dengue. Geneva, Switzerland: World Health Organization.
15. Hemungkorn M, Thisyakorn U, Thisyakorn C, 2007. Dengue infection: a growing global health threat. Biosci Trends 1: 90-96.
16. Halstead SB, 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239: 476-481.
17. Webster DP, Farrar J, Rowland-Jones S, 2009. Progress towards a dengue vaccine. Lancet Infect Dis 9: 678-687.
18. Isturiz RE, Gubler DJ, Castillo JB, 2000. Dengue and dengue hemorrhagic fever in Latin America and the Caribbean. Infect Dis Clin North Am 14: 121-140.
19. Nishiura H, 2008. Duration of short-lived cross-protection immunity against a clinical attack of dengue: a preliminary estimate. Dengue Bull 32: 55-66.
20. Halstead SB, 2003. Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 60: 421-467.
21. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS, 1989. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop MedHyg 40: 444-451.
22. Schieffelin JS, Costin JM, Nicholson CO, Orgeron NM, Fontaine KA, Isern S, Michael SF, Robinson JE, 2010. Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient. Virol J 7: 28.
23. Wilder-Smith A, Ooi EE, Vasudevan SG, Gubler DJ, 2010. Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Curr Infect Dis Rep 12: 157-164.
24. Morens DM, Fauci AS, 2008. Dengue and hemorrhagic fever: a potential threat to public health in the United States. JAMA 299: 214-216.
25. Departamento de Salud Gobierno de Puerto Rico, CDC Dengue Branch, 2011. Informe Semanal de Vigilancia de Dengue. Available at: http://www.salud.gov.pr/ Datos/VDengue/DengueInfo/Pages/DatosEstadisticos.aspx. Accessed September 7, 2011.
26. Centers for Disease Control Dengue Branch, Puerto Rico Department of Health, 2010. Dengue Update. Available at: http://www.cdc.gov/Dengue/dengue-upd/ index.html. Accessed May 11, 2011.
27. Perez-Guerra C, Halasa Y, Rivera R, Peña M, Ramírez V, Cano MP, Shepard DS, 2010. Economic cost of dengue public prevention activities in Puerto Rico. Dengue Bull 34: 13-23.
28. Rigau-Perez JG, Clark GG, 2005. How to respond to a dengue epidemic: overview and experience in Puerto Rico. Rev Panam Salud Publica 17: 282-293.
29. Winch P, Leontsini E, Rigau-Perez JG, Ruiz-Perez M, Clark GG, Gubler DJ, 2002. Community-based dengue prevention programs in Puerto Rico: impact on knowledge, behavior, and residential mosquito infestation. Am J Trop Med Hyg 67: 363-370.
30. Tomashek KM, Rivera A, Munoz-Jordan JL, Hunsperger E, Santiago L, Padro O, Garcia E, Sun W, 2009. Description of a large island-wide outbreak of dengue in Puerto Rico, 2007. Am J Trop Med Hyg 81: 467-474.
31. Von Allmen SD, Lopez-Correa RH, Woodall JP, Morens DM, Chiriboga J, Casta-Velez A, 1979. Epidemic dengue fever in Puerto Rico, 1977: a cost analysis. Am J Trop Med Hyg 28: 1040-1044.
32. Rodriguez E, 1997. Dengue Outbreak in Puerto Rico (1994-95): Hospitalization Cost Analysis. Geneva, Switzerland: World Health Organization.
33. Centers for Disease Control and Prevention/Division of Vector Borne and Infectious Diseases, 2011. Dengue in Puerto Rico. Available at: http://www.cdc.gov/dengue/about/inPuerto.html. Accessed January 9, 2011.
34. World Health Organization (WHO), 1997. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. Geneva, Switzerland: World Health Organization.
35. Hayashi AS, Finnegan B, Shin P, Jones E, Rosenbaum S, 2009. Examining the Experiences of Puerto Rico's Community Health Centers under the Government Health Insurance Plan, Policy Research Brief No. 8. Washington, DC: George Washington University School of Public Health and Health Services.
36. US Census Bureau, 2003. School Enrollment 2000. Table 1. Population Aged 3 and Over by Enrollment Status and Level for the United States, Regions, States, and for Puerto Rico: 1990 and 2000. Available at: http://www.census.gov/ prod/2003pubs/c2kbr-26.pdf. Accessed January 19, 2011.
37. Central Intelligence Agency, 2008. Federal and State Minimum Wage Rates, Laws, and Resources. Available at: http://www.minimum-wage.org/states.asp?state= Puerto%20Rico. Accessed January 20, 2011.
38. Dechant EJ, Rigau-Perez JG; Puerto Rico Association of Epidemiologists, 1999. Hospitalizations for suspected dengue in Puerto Rico, 1991-1995: estimation by capture-recatpure methods. Am J Trop Med Hyg 61: 574-578.
39. Meltzer MI, Rigau-Perez JG, Clark GG, Reiter P, Gubler DJ, 1998. Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984-1994. Am J Trop Med Hyg 59: 265-271.
40. Ramos MM, Argüello DF, Luxemburger C, Quiñones L, Muñoz JL, Beatty M, Lang J, Tomashek KM, 2008. Epidemiological and clinical observations on patients with dengue in Puerto Rico: results from the first year of enhanced surveillance-June 2005-May 2006. Am J Trop Med Hyg 79: 123-127.
41. Perez-Guerra C, Zielinski-Gutierrez E, Vargas-Torres D, Clark G, 2009. Community beliefs and practices about dengue in Puerto Rico. Rev Panam Salud Publica 25: 218-226.
42. Rivera A, Tomashek KM, Munoz J, Hunsperger E, Blau D, Sharp T, Torres J; Infectious Diseases Pathology Branch, Gonzalez L, Deseda C, Rivera I, Sanabria D, Torres J, Rodriguez R, Serrano J, Davila F, Lopez D, Margolis H, 2011. Enhanced Surveillance for Fatal Dengue in Puerto Rico. Presented at the American Society of Tropical Medicine and Hygiene 60th Annual Meeting. Philadelphia, PA, December 4-8, Abstract 1335.
43. US Social Security Administration, Actuarial Publications, Period Life Table, 2007. Available at: http://www.ssa.gov/oact/STATS/table4c6.html. Accessed November 1, 2011.
44. Neff JM, Morris L, Gonzalez-Alcover R, Coleman PH, Lyss SB, Negron H, 1967. Dengue fever in a Puerto Rican community. Am J Epidemiol 86: 162-184.
45. Welcome to Puerto Rico, 2006. Economy. Available at: http://www. topuertorico.org/economy.shtml. Accessed October 21, 2010.
46. Akazawa M, Sindelar JL, Paltiel AD, 2003. Economic costs of influenza-related work absenteeism. Value Health 6: 107-115.
47. Keech M, Beardsworth P, 2008. The impact of influenza on working days lost: a review of the literature. Pharmacoeconomics 26: 911-924.
48. Niemela M, Uhari M, Mottonen M, Pokka T, 1999. Costs arising from otitis media. Acta Paediatr 88: 553-556.
49. Greenberg D, Bilenko N, Liss Z, Shagan T, Zamir O, Dagan R, 2003. The burden of acute otitis media on the patient and the family. Eur J Pediatr 162: 576-581.
50. Anderson KB, Chunsuttiwat S, Nisalak A, Mammen MP Jr, Libraty DH, Rothman AL, Green S, Vaughn DW, Ennis FA, Endy TP, 2007. Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet 369: 1452-1459.
51. Añez G, Balza R, Valero N, Larreal Y, 2006. Impacto económico del dengue y del dengue hemorrágico en el Estado de Zulia, Venezuela, 1997-2003. Rev Panam Salud Publica 19: 314-320.
52. Armien B, Suaya JA, Quiroz E, Sah BK, Bayard V, Marchena L, Campos C, Shepard DS, 2008. Clinical characteristics and national economic cost of the 2005 dengue epidemic in Panama. Am J Trop Med Hyg 79: 364-371.
53. Canyon DV, 2008. Historical analysis of the economic cost of dengue in Australia. J Vector Dis 45: 245-248.
54. Chandralekha GP, Trikha A, 2008. The north Indian dengue outbreak 2006: a retrospective analysis of intensive care unit admissions in a tertiary care hospital. Trans R Soc Trop Med Hyg 102: 143-147.
55. Clark DV, Mammen MP Jr, Nisalak A, Puthimethee V, Endy TP, 2005. Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels. Am J Trop Med Hyg 72: 786-791.
56. Coudeville L, Shepard DS, Zambrano B, Dayan G, 2009. Dengue Economic Burden in the Americas: Estimates from Dengue Illness. Washington, DC. Presented at the American Society of Tropical Medicine and Hygiene 58th Annual Meeting, Washington, DC, November 18-22, poster 442.
57. Garg P, Nagpal J, Kairnar P, Sinveratne SL, 2008. Economic burden of dengue infections in India. Trans R Soc Trop Med Hyg 102: 570-577.
58. Huy R, Wichmann O, Beatty M, Ngan C, Duong S, Margolis HS, Vong S, 2009. Cost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control study. BMC Public Health 9: 155.
59. Torres JR, Castro J, 2007. The health and economic impact of dengue in Latin America 1. Cad Saude Publica 23 (Suppl 1): S23-S31.
60. Valdés LG, Mizhrahi JV, Guzmán MG, 2002. Impacto económico de la epidemia de dengue 2 en Santiago de Cuba, 1997. Rev Cubana Med Trop 54: 220-227.
61. Kongsin S, Jaimton S, Suaya J, Vasanawathana S, Sirisuvan P, Shepard DS, 2010. Cost of dengue in Thailand. Dengue Bull 34: 77-88.
62. Pan American Health Organization (PAHO), Fact Sheet: Dengue. Available at: http://new.paho.org/hq/index.php?option=com-content&task=view&id= 264&Itemid=363&lang=en. Accessed November 1, 2011.
63. Allwinn R, Hofknecht N, Doerr HW, 2008. 12 Denue in travelers is still underestimated. Intervirology 12: 695-699.
64. LaRouche G, Renaudat C, Tarantola A, Caro V, Ledrans M, Dejour-Salamanca D, Diancourt L, Tolou H, Grandadam M, Gastellu-Etchegorry M, 2010. Increase in dengue fever imported from Cote d'Ivoire and West Africa to France. Dengue Bull 34: 24-31.
65. World Health Organization (WHO), 2010. Weekly Epidemiological Monitor. Cairo, Egypt: Regional Office of the Eastern Mediterranean.
66. Mavalankar D, Puwar T, Murtola T, Vasan S in collaboration with Field R, Alphey N, Gong H-F, Shepard DS, 2009. Quantifying the Impact of Chikungunya and Dengue on Tourism Revenues. W.P.No. 2009-02-03. Ahmedabad, India: Indian Institute of Management Working Paper Series. Available at: http://www.iimahd. ernet.in/publications/data/2009-02-03Mavalankar.pdf. Accessed July 30, 2009.
67. Pan American Health Organization (PAHO), 2007. Health Systems Profile Puerto Rico: Monitoring and Analysis Health Systems Change/Reform. Washington, DC: Pan American Health Organization and USAID.